Suspension of trading
Sector Eiger BioPharmaceuticals
Stocks
EIGR
US28249U2042
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 24-10-01 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 24-09-30 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -72.76% | -96.48% | -98.74% | 12.59M | |
| -0.58% | +0.91% | +2.49% | +1.14% | -8.89% | -16.01% | -12.78% | -26.27% | +206.83% | 42.96B | |
| +3.50% | -4.15% | +3.52% | +49.84% | +87.36% | +265.85% | +484.30% | +335.45% | - | 31.73B | |
| -0.61% | -3.11% | +4.33% | +5.53% | -19.68% | +14.00% | -12.36% | -25.62% | +176.13% | 30.22B | |
| -1.27% | -7.02% | -16.24% | -12.93% | -14.33% | -0.82% | +20.47% | -24.97% | +777.22% | 28.94B | |
| -0.66% | -5.84% | -8.78% | -16.50% | -3.59% | +7.59% | +12.76% | -23.86% | +140.60% | 23.87B | |
| +2.01% | +3.57% | +13.85% | -0.55% | -15.42% | +57.15% | +128.55% | +171.22% | - | 13.57B | |
| -0.40% | -1.29% | +8.24% | +3.92% | +2.69% | +6.06% | +7.59% | -26.45% | +100.41% | 12.96B | |
| +2.77% | -1.48% | -9.67% | - | - | - | - | - | - | 13.39B | |
| +0.68% | -1.74% | -2.07% | -1.30% | -6.69% | +103.98% | +81.60% | +94.62% | +239.40% | 12.2B | |
| +3.69% | -1.88% | +26.03% | +42.27% | -17.73% | +3.01% | -32.45% | -30.65% | +121.97% | 11.48B | |
| -3.72% | -11.15% | -27.95% | -16.78% | -6.24% | +20.18% | +2,955.56% | - | - | 9.76B | |
| +0.95% | +1.22% | +11.63% | +11.34% | -5.72% | +24.45% | -4.87% | -46.59% | +121.95% | 9.06B | |
| +0.22% | -5.11% | +2.33% | -5.87% | -16.02% | -29.94% | - | - | - | 8.9B | |
| +2.90% | +1.58% | +13.92% | +0.75% | -8.14% | +4.81% | -31.12% | -51.33% | +91.09% | 8.46B | |
| +0.88% | -2.22% | -17.16% | -16.44% | -28.65% | +1,274.40% | +456.35% | +173.57% | +870.62% | 7.82B | |
| +1.08% | -0.37% | +14.68% | -9.20% | -20.95% | -23.91% | -25.98% | -29.97% | +48.70% | 7.74B | |
| +2.46% | +3.55% | +26.64% | +61.76% | +60.54% | +43.97% | +44.30% | +79.46% | +5.32% | 7.49B | |
| +3.80% | +6.81% | +6.08% | +13.80% | +25.70% | +98.39% | +277.41% | +176.97% | - | 7.06B | |
| +3.04% | -6.33% | -25.26% | -16.50% | -15.86% | +456.07% | +1,572.60% | -17.63% | - | 6.91B | |
| Average | +1.04% | -1.41% | +1.33% | +4.96% | -0.61% | +121.54% | +324.95% | +37.15% | +215.50% | 14.73B | |
| Weighted average by Cap. | +0.71% | -2.09% | +0.43% | +5.98% | +2.31% | +87.63% | +230.92% | +46.56% | +269.56% |
- Stock Market
- Stocks
- EIGR Stock
- Sector Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
